Correlation Between NYSE Composite and Minerva Neurosciences
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Minerva Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Minerva Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Minerva Neurosciences, you can compare the effects of market volatilities on NYSE Composite and Minerva Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Minerva Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Minerva Neurosciences.
Diversification Opportunities for NYSE Composite and Minerva Neurosciences
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NYSE and Minerva is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Minerva Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Minerva Neurosciences and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Minerva Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Minerva Neurosciences has no effect on the direction of NYSE Composite i.e., NYSE Composite and Minerva Neurosciences go up and down completely randomly.
Pair Corralation between NYSE Composite and Minerva Neurosciences
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.18 times more return on investment than Minerva Neurosciences. However, NYSE Composite is 5.65 times less risky than Minerva Neurosciences. It trades about 0.41 of its potential returns per unit of risk. Minerva Neurosciences is currently generating about -0.19 per unit of risk. If you would invest 1,925,354 in NYSE Composite on September 2, 2024 and sell it today you would earn a total of 101,850 from holding NYSE Composite or generate 5.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Minerva Neurosciences
Performance |
| Timeline |
NYSE Composite and Minerva Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Minerva Neurosciences
Pair trading matchups for Minerva Neurosciences
Pair Trading with NYSE Composite and Minerva Neurosciences
The main advantage of trading using opposite NYSE Composite and Minerva Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Minerva Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will offset losses from the drop in Minerva Neurosciences' long position.| NYSE Composite vs. Simon Property Group | NYSE Composite vs. Merit Medical Systems | NYSE Composite vs. Catalent | NYSE Composite vs. Titan Machinery |
| Minerva Neurosciences vs. Reviva Pharmaceuticals Holdings | Minerva Neurosciences vs. Eyenovia | Minerva Neurosciences vs. Cognition Therapeutics | Minerva Neurosciences vs. Transcode Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |